O	O	0	8	Platelet	Platelet	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	8	9	-	-	O	HYPH	I-protein	1	P	I-protein
O	O	9	19	activating	activate	B-VP	VBG	I-protein	4	NMOD	I-protein
O	O	20	26	factor	factor	B-NP	NN	I-protein	5	SUB	I-protein
O	O	27	34	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	35	47	phospholipid	phospholipid	B-NP	JJ	O	7	NMOD	O
O	O	48	56	turnover	turnover	I-NP	NN	O	21	NMOD	O
O	O	56	57	,	,	O	,	O	21	P	O
O	O	58	65	calcium	calcium	B-NP	NN	O	10	NMOD	O
O	O	66	70	flux	flux	I-NP	NN	O	21	NMOD	O
O	O	70	71	,	,	O	,	O	21	P	O
O	O	72	83	arachidonic	arachidonic	B-NP	JJ	O	14	NMOD	O
O	O	84	88	acid	acid	I-NP	NN	O	14	NMOD	O
O	O	89	99	liberation	liberation	I-NP	NN	O	21	NMOD	O
O	O	99	100	,	,	O	,	O	21	P	O
O	O	101	111	eicosanoid	eicosanoid	B-NP	NN	O	17	NMOD	O
O	O	112	122	generation	generation	I-NP	NN	O	21	NMOD	O
O	O	122	123	,	,	O	,	O	21	P	O
O	O	124	127	and	and	O	CC	O	21	NMOD	O
T5	B-Entity	128	136	oncogene	oncogene	B-NP	NN	B-DNA	21	NMOD	B-DNA
O	O	137	147	expression	expression	I-NP	NN	O	5	OBJ	O
O	O	148	150	in	in	B-PP	IN	O	5	VMOD	O
O	O	151	152	a	a	B-NP	DT	O	27	NMOD	O
O	O	153	158	human	human	I-NP	JJ	B-cell_line	27	NMOD	B-cell_line
O	O	159	160	B	B	I-NP	NN	I-cell_line	27	NMOD	I-cell_line
O	O	161	165	cell	cell	I-NP	NN	I-cell_line	27	NMOD	I-cell_line
O	O	166	170	line	line	I-NP	NN	I-cell_line	22	PMOD	I-cell_line
O	O	170	171	.	.	O	.	O	5	P	O

O	O	173	181	Platelet	Platelet	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	181	182	-	-	O	HYPH	I-protein	1	P	I-protein
O	O	182	192	activating	activate	B-VP	VBG	I-protein	4	NMOD	I-protein
O	O	193	199	factor	factor	B-NP	NN	I-protein	5	SUB	I-protein
O	O	200	202	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	203	204	a	a	B-NP	DT	O	8	NMOD	O
O	O	205	211	potent	potent	I-NP	JJ	O	8	NMOD	O
O	O	212	220	mediator	mediator	I-NP	NN	O	5	PRD	O
O	O	221	223	of	of	B-PP	IN	O	8	NMOD	O
O	O	224	227	the	the	B-NP	DT	O	12	NMOD	O
O	O	228	240	inflammatory	inflammatory	I-NP	JJ	O	12	NMOD	O
O	O	241	249	response	response	I-NP	NN	O	9	PMOD	O
O	O	249	250	.	.	O	.	O	5	P	O

O	O	251	258	Studies	Study	B-NP	NNS	O	10	SUB	O
O	O	259	261	of	of	B-PP	IN	O	1	NMOD	O
O	O	262	265	the	the	B-NP	DT	O	4	NMOD	O
O	O	266	273	actions	action	I-NP	NNS	O	2	PMOD	O
O	O	274	276	of	of	B-PP	IN	O	4	NMOD	O
O	O	277	285	platelet	platelet	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	285	286	-	-	O	HYPH	I-protein	6	P	I-protein
O	O	286	296	activating	activate	B-VP	VBG	I-protein	9	NMOD	I-protein
O	O	297	303	factor	factor	B-NP	NN	I-protein	5	PMOD	I-protein
O	O	304	308	have	have	B-VP	VBP	O	0	ROOT	O
O	O	309	317	centered	center	I-VP	VBN	O	10	VC	O
O	O	318	324	mainly	mainly	B-ADVP	RB	O	13	PMOD	O
O	O	325	331	around	around	B-PP	IN	O	11	VMOD	O
O	O	332	343	neutrophils	neutrophil	B-NP	NNS	B-cell_type	19	NMOD	B-cell_type
O	O	343	344	,	,	O	,	O	19	P	O
O	O	345	354	monocytes	monocyte	B-NP	NNS	B-cell_type	19	NMOD	B-cell_type
O	O	354	355	,	,	O	,	O	19	P	O
O	O	356	359	and	and	O	CC	O	19	NMOD	O
O	O	360	369	platelets	platelet	B-NP	NNS	B-cell_type	13	PMOD	B-cell_type
O	O	369	370	.	.	O	.	O	10	P	O

O	O	371	373	In	In	B-PP	IN	O	5	VMOD	O
O	O	374	378	this	this	B-NP	DT	O	3	NMOD	O
O	O	379	385	report	report	I-NP	NN	O	1	PMOD	O
O	O	386	388	we	we	B-NP	PRP	O	5	SUB	O
O	O	389	394	begin	begin	B-VP	VBP	O	0	ROOT	O
O	O	395	397	to	to	I-VP	TO	O	7	VMOD	O
O	O	398	405	uncover	uncover	I-VP	VB	O	5	VMOD	O
O	O	406	409	the	the	B-NP	DT	O	9	NMOD	O
O	O	410	419	influence	influence	I-NP	NN	O	7	OBJ	O
O	O	420	422	of	of	B-PP	IN	O	9	NMOD	O
O	O	423	431	platelet	platelet	B-NP	NN	B-protein	10	PMOD	B-protein
O	O	431	432	-	-	O	HYPH	I-protein	14	NMOD	I-protein
O	O	432	442	activating	activate	B-VP	VBG	I-protein	14	NMOD	I-protein
O	O	443	449	factor	factor	B-NP	NN	I-protein	11	NMOD	I-protein
O	O	450	452	on	on	B-PP	IN	O	9	NMOD	O
O	O	453	454	B	B	B-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	455	466	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	466	467	.	.	O	.	O	5	P	O

O	O	468	477	Employing	Employ	B-VP	VBG	O	15	VMOD	O
O	O	478	481	the	the	B-NP	DT	O	3	NMOD	O
O	O	482	485	EBV	EBV	I-NP	NN	O	1	OBJ	O
O	O	485	486	-	-	B-VP	HYPH	O	3	NMOD	O
O	O	486	497	transformed	transform	B-NP	VBN	B-cell_line	10	NMOD	B-cell_line
O	O	498	503	human	human	I-NP	JJ	I-cell_line	10	NMOD	I-cell_line
O	O	504	505	B	B	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	506	510	cell	cell	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	511	515	line	line	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	516	520	SKW6	SKW6	I-NP	NN	I-cell_line	4	OBJ	I-cell_line
O	O	520	521	.	.	O	.	O	10	P	O
O	O	521	522	4	4	B-NP	CD	O	10	NMOD	O
O	O	522	523	,	,	O	,	O	15	P	O
O	O	524	526	we	we	B-NP	PRP	O	15	SUB	O
O	O	527	538	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	539	543	that	that	B-SBAR	IN	O	15	VMOD	O
O	O	544	552	platelet	platelet	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	552	553	-	-	O	HYPH	I-protein	17	P	I-protein
O	O	553	563	activating	activate	B-VP	VBG	I-protein	20	NMOD	I-protein
O	O	564	570	factor	factor	B-NP	NN	I-protein	22	SUB	I-protein
O	O	571	584	significantly	significantly	B-ADVP	RB	O	22	VMOD	O
O	O	585	591	alters	alter	B-VP	VBZ	O	16	SBAR	O
O	O	592	600	membrane	membrane	B-NP	NN	O	25	NMOD	O
O	O	601	613	phospholipid	phospholipid	I-NP	NN	O	25	NMOD	O
O	O	614	624	metabolism	metabolism	I-NP	NN	O	22	OBJ	O
O	O	625	634	indicated	indicate	B-VP	VBN	O	25	NMOD	O
O	O	635	637	by	by	B-PP	IN	O	26	VMOD	O
O	O	638	641	the	the	B-NP	DT	O	29	NMOD	O
O	O	642	655	incorporation	incorporation	I-NP	NN	O	27	PMOD	O
O	O	656	658	of	of	B-PP	IN	O	29	NMOD	O
O	O	659	662	32P	32P	B-NP	NN	O	30	PMOD	O
O	O	663	667	into	into	B-PP	IN	O	29	NMOD	O
O	O	668	687	phosphatidylcholine	phosphatidylcholine	B-NP	NN	O	39	NMOD	O
O	O	687	688	,	,	O	,	O	39	P	O
O	O	689	709	phosphatidylinositol	phosphatidylinositol	B-NP	NN	O	39	NMOD	O
O	O	709	710	,	,	O	,	O	39	P	O
O	O	711	714	and	and	O	CC	O	39	NMOD	O
O	O	715	727	phosphatidic	phosphatidic	B-NP	JJ	O	39	NMOD	O
O	O	728	732	acid	acid	I-NP	NN	O	32	PMOD	O
O	O	733	736	but	but	B-PP	CC	O	32	PMOD	O
O	O	737	740	not	not	B-ADVP	RB	O	43	PMOD	O
O	O	741	754	significantly	significantly	I-ADVP	RB	O	41	AMOD	O
O	O	755	759	into	into	B-PP	IN	O	32	PMOD	O
O	O	760	784	phosphatidylethanolamine	phosphatidylethanolamine	B-NP	NN	O	43	PMOD	O
O	O	785	787	at	at	B-PP	IN	O	29	NMOD	O
O	O	788	802	concentrations	concentration	B-NP	NNS	O	55	NMOD	O
O	O	803	810	ranging	range	B-VP	VBG	O	46	NMOD	O
O	O	811	815	from	from	B-PP	IN	O	47	VMOD	O
O	O	816	818	10	10	B-NP	CD	O	48	PMOD	O
O	O	818	819	(	(	O	(	O	53	DEP	O
O	O	819	820	-	-	O	SYM	O	53	DEP	O
O	O	820	821	9	9	B-NP	CD	O	51	PRD	O
O	O	821	822	)	)	O	)	O	46	NMOD	O
O	O	823	825	to	to	B-PP	TO	O	55	AMOD	O
O	O	826	828	10	10	B-NP	CD	O	60	NMOD	O
O	O	828	829	(	(	O	(	O	59	DEP	O
O	O	829	830	-	-	O	SYM	O	59	DEP	O
O	O	830	831	6	6	O	CD	O	57	PRD	O
O	O	831	832	)	)	O	)	O	55	NMOD	O
O	O	833	834	M	M	B-NP	NN	O	45	PMOD	O
O	O	834	835	.	.	O	.	O	15	P	O

O	O	836	839	The	The	B-NP	DT	O	3	NMOD	O
O	O	840	848	inactive	inactive	I-NP	JJ	O	3	NMOD	O
O	O	849	858	precursor	precursor	I-NP	NN	O	10	NMOD	O
O	O	858	859	,	,	O	,	O	10	P	O
O	O	860	864	lyso	lyso	O	AFX	O	10	NMOD	O
O	O	864	865	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	865	873	platelet	platelet	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	873	874	-	-	O	HYPH	I-protein	10	NMOD	I-protein
O	O	874	884	activating	activate	B-VP	VBG	I-protein	10	NMOD	I-protein
O	O	885	891	factor	factor	B-NP	NN	I-protein	24	SUB	I-protein
O	O	891	892	,	,	O	,	O	10	P	O
O	O	893	895	at	at	B-PP	IN	O	10	NMOD	O
O	O	896	897	a	a	B-NP	DT	O	14	NMOD	O
O	O	898	911	concentration	concentration	I-NP	NN	O	12	PMOD	O
O	O	912	914	as	as	B-ADJP	RB	O	16	AMOD	O
O	O	915	919	high	high	I-ADJP	JJ	O	14	NMOD	O
O	O	920	922	as	as	B-PP	IN	O	16	AMOD	O
O	O	923	925	10	10	B-NP	CD	O	23	NMOD	O
O	O	925	926	(	(	O	(	O	22	DEP	O
O	O	926	927	-	-	O	SYM	O	22	DEP	O
O	O	927	928	7	7	O	CD	O	20	PRD	O
O	O	928	929	)	)	O	)	O	18	NMOD	O
O	O	930	931	M	M	B-NP	NN	O	17	PMOD	O
O	O	932	935	had	have	B-VP	VBD	O	0	ROOT	O
O	O	936	938	no	no	B-NP	DT	O	26	NMOD	O
O	O	939	945	effect	effect	I-NP	NN	O	24	OBJ	O
O	O	946	948	on	on	B-PP	IN	O	24	VMOD	O
O	O	949	952	any	any	B-NP	DT	O	27	PMOD	O
O	O	953	955	of	of	B-PP	IN	O	28	NMOD	O
O	O	956	959	the	the	B-NP	DT	O	32	NMOD	O
O	O	960	968	membrane	membrane	I-NP	NN	O	32	NMOD	O
O	O	969	982	phospholipids	phospholipid	I-NP	NNS	O	29	PMOD	O
O	O	982	983	.	.	O	.	O	24	P	O

O	O	984	986	We	We	B-NP	PRP	O	3	SUB	O
O	O	987	991	also	also	B-ADVP	RB	O	3	VMOD	O
O	O	992	996	show	show	B-VP	VBP	O	0	ROOT	O
O	O	997	1001	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1002	1010	platelet	platelet	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	1010	1011	-	-	O	HYPH	I-protein	5	P	I-protein
O	O	1011	1021	activating	activate	B-VP	VBG	I-protein	8	NMOD	I-protein
O	O	1022	1028	factor	factor	B-NP	NN	I-protein	16	NMOD	I-protein
O	O	1029	1033	from	from	B-PP	IN	O	8	NMOD	O
O	O	1034	1036	10	10	B-NP	CD	O	9	PMOD	O
O	O	1036	1037	(	(	O	(	O	14	DEP	O
O	O	1037	1038	-	-	O	SYM	O	14	DEP	O
O	O	1038	1040	12	12	B-NP	CD	O	12	PRD	O
O	O	1040	1041	)	)	O	)	O	8	NMOD	O
O	O	1042	1044	to	to	B-PP	TO	O	16	AMOD	O
O	O	1045	1047	10	10	B-NP	CD	O	21	NMOD	O
O	O	1047	1048	(	(	O	(	O	20	DEP	O
O	O	1048	1049	-	-	O	SYM	O	20	DEP	O
O	O	1049	1050	6	6	O	CD	O	18	PRD	O
O	O	1050	1051	)	)	O	)	O	16	NMOD	O
O	O	1052	1053	M	M	B-NP	NN	O	22	SUB	O
O	O	1054	1061	induced	induce	B-VP	VBD	O	4	SBAR	O
O	O	1062	1067	rapid	rapid	B-NP	JJ	O	25	AMOD	O
O	O	1068	1071	and	and	I-NP	CC	O	25	AMOD	O
O	O	1072	1083	significant	significant	I-NP	JJ	O	26	NMOD	O
O	O	1084	1093	elevation	elevation	I-NP	NN	O	22	OBJ	O
O	O	1094	1096	in	in	B-PP	IN	O	26	NMOD	O
O	O	1097	1110	intracellular	intracellular	B-NP	JJ	O	30	NMOD	O
O	O	1111	1118	calcium	calcium	I-NP	NN	O	30	NMOD	O
O	O	1119	1125	levels	level	I-NP	NNS	O	27	PMOD	O
O	O	1125	1126	,	,	O	,	O	22	P	O
O	O	1127	1134	whereas	whereas	O	IN	O	22	VMOD	O
O	O	1135	1139	lyso	lyso	O	AFX	O	38	NMOD	O
O	O	1139	1140	-	-	B-NP	HYPH	O	38	NMOD	O
O	O	1140	1148	platelet	platelet	I-NP	NN	B-protein	38	NMOD	B-protein
O	O	1148	1149	-	-	O	HYPH	I-protein	38	NMOD	I-protein
O	O	1149	1159	activating	activate	B-VP	VBG	I-protein	38	NMOD	I-protein
O	O	1160	1166	factor	factor	B-NP	NN	I-protein	39	SUB	I-protein
O	O	1167	1170	was	be	B-VP	VBD	O	32	SBAR	O
O	O	1171	1176	again	again	B-ADJP	RB	O	41	AMOD	O
O	O	1177	1188	ineffective	ineffective	I-ADJP	JJ	O	39	PRD	O
O	O	1188	1189	.	.	O	.	O	3	P	O

O	O	1190	1192	We	We	B-NP	PRP	O	3	SUB	O
O	O	1193	1200	further	further	B-ADVP	RB	O	3	VMOD	O
O	O	1201	1212	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	1213	1216	the	the	B-NP	DT	O	5	NMOD	O
O	O	1217	1223	impact	impact	I-NP	NN	O	3	OBJ	O
O	O	1224	1226	of	of	B-PP	IN	O	5	NMOD	O
O	O	1227	1235	platelet	platelet	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	1235	1236	-	-	O	HYPH	I-protein	7	P	I-protein
O	O	1236	1246	activating	activate	B-VP	VBG	I-protein	10	NMOD	I-protein
O	O	1247	1253	factor	factor	B-NP	NN	I-protein	11	NMOD	I-protein
O	O	1254	1261	binding	binding	I-NP	NN	O	6	PMOD	O
O	O	1262	1264	to	to	B-PP	TO	O	11	NMOD	O
O	O	1265	1266	B	B	B-NP	NN	B-cell_type	14	NMOD	B-cell_type
O	O	1267	1272	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	1273	1275	by	by	B-PP	IN	O	3	VMOD	O
O	O	1276	1285	measuring	measure	B-VP	VBG	O	15	PMOD	O
O	O	1286	1294	platelet	platelet	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	1294	1295	-	-	O	HYPH	I-protein	17	P	I-protein
O	O	1295	1305	activating	activate	B-VP	VBG	I-protein	24	NMOD	I-protein
O	O	1306	1312	factor	factor	B-NP	NN	I-protein	24	NMOD	I-protein
O	O	1313	1320	induced	induced	I-NP	JJ	O	24	NMOD	O
O	O	1321	1332	arachidonic	arachidonic	I-NP	JJ	O	24	NMOD	O
O	O	1333	1337	acid	acid	I-NP	NN	O	24	NMOD	O
O	O	1338	1345	release	release	I-NP	NN	O	30	NMOD	O
O	O	1346	1349	and	and	O	CC	O	30	NMOD	O
O	O	1350	1351	5	5	B-NP	CD	O	30	NMOD	O
O	O	1351	1352	-	-	I-NP	HYPH	O	30	NMOD	O
O	O	1352	1375	hydroxyeicosatetraenoic	hydroxyeicosatetraenoic	I-NP	JJ	O	30	NMOD	O
O	O	1376	1380	acid	acid	I-NP	NN	O	30	NMOD	O
O	O	1381	1391	production	production	I-NP	NN	O	16	OBJ	O
O	O	1391	1392	.	.	O	.	O	3	P	O

O	O	1393	1401	Moreover	Moreover	B-ADVP	RB	O	7	VMOD	O
O	O	1401	1402	,	,	O	,	O	7	P	O
O	O	1403	1411	platelet	platelet	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	1411	1412	-	-	O	HYPH	I-protein	6	NMOD	I-protein
O	O	1412	1422	activating	activate	B-VP	VBG	I-protein	6	NMOD	I-protein
O	O	1423	1429	factor	factor	B-NP	NN	I-protein	7	SUB	I-protein
O	O	1430	1433	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1434	1441	capable	capable	B-ADJP	JJ	O	7	PRD	O
O	O	1442	1444	of	of	B-PP	IN	O	8	AMOD	O
O	O	1445	1453	inducing	induce	B-VP	VBG	O	9	PMOD	O
O	O	1454	1467	transcription	transcription	B-NP	NN	O	10	OBJ	O
O	O	1468	1470	of	of	B-PP	IN	O	11	NMOD	O
O	O	1471	1474	the	the	B-NP	DT	O	24	NMOD	O
T6	B-Entity	1475	1482	nuclear	nuclear	I-NP	JJ	B-DNA	17	NMOD	B-DNA
T6	I-Entity	1483	1488	proto	proto	I-NP	AFX	I-DNA	17	NMOD	I-DNA
T6	I-Entity	1488	1489	-	-	I-NP	HYPH	I-DNA	17	NMOD	I-DNA
T6	I-Entity	1489	1498	oncogenes	oncogene	I-NP	NNS	I-DNA	24	NMOD	I-DNA
T1	B-Protein	1499	1500	c	c	I-NP	NN	O	24	NMOD	O
T1	I-Protein	1500	1501	-	-	B-NP	HYPH	O	24	P	O
T1	I-Protein	1501	1504	fos	fos	I-NP	NN	O	24	NMOD	O
O	O	1505	1508	and	and	I-NP	CC	O	24	NMOD	O
T2	B-Protein	1509	1510	c	c	I-NP	NN	B-DNA	24	NMOD	B-DNA
T2	I-Protein	1510	1511	-	-	B-NP	HYPH	I-DNA	24	NMOD	I-DNA
T2	I-Protein	1511	1514	jun	jun	I-NP	NN	I-DNA	12	PMOD	I-DNA
O	O	1514	1515	.	.	O	.	O	7	P	O

O	O	1516	1523	Finally	Finally	B-ADVP	RB	O	3	VMOD	O
O	O	1524	1526	we	we	B-NP	PRP	O	3	SUB	O
O	O	1527	1535	explored	explore	B-VP	VBD	O	0	ROOT	O
O	O	1536	1539	the	the	B-NP	DT	O	6	NMOD	O
O	O	1540	1548	possible	possible	I-NP	JJ	O	6	NMOD	O
O	O	1549	1553	role	role	I-NP	NN	O	3	OBJ	O
O	O	1554	1556	of	of	B-PP	IN	O	6	NMOD	O
O	O	1557	1558	5	5	B-NP	CD	O	11	NMOD	O
O	O	1558	1559	-	-	I-NP	HYPH	O	11	NMOD	O
O	O	1559	1582	hydroxyeicosatetraenoic	hydroxyeicosatetraenoic	I-NP	JJ	O	11	NMOD	O
O	O	1583	1587	acid	acid	I-NP	NN	O	7	PMOD	O
O	O	1588	1590	as	as	B-PP	IN	O	3	VMOD	O
O	O	1591	1592	a	a	B-NP	DT	O	14	NMOD	O
O	O	1593	1602	regulator	regulator	I-NP	NN	O	12	PMOD	O
O	O	1603	1605	of	of	B-PP	IN	O	14	NMOD	O
O	O	1606	1617	arachidonic	arachidonic	B-NP	JJ	O	18	NMOD	O
O	O	1618	1622	acid	acid	I-NP	NN	O	18	NMOD	O
O	O	1623	1633	liberation	liberation	I-NP	NN	O	15	PMOD	O
O	O	1634	1647	demonstrating	demonstrate	B-VP	VBG	O	3	VMOD	O
O	O	1648	1652	that	that	B-SBAR	IN	O	19	VMOD	O
O	O	1653	1663	endogenous	endogenous	B-NP	JJ	B-protein	25	NMOD	B-protein
T3	B-Protein	1664	1665	5	5	I-NP	CD	I-protein	21	NMOD	I-protein
T3	I-Protein	1665	1666	-	-	I-NP	HYPH	O	21	P	O
T3	I-Protein	1666	1678	lipoxygenase	lipoxygenase	I-NP	NN	B-protein	25	NMOD	B-protein
O	O	1679	1687	activity	activity	I-NP	NN	O	26	SUB	O
O	O	1688	1697	modulates	modulate	B-VP	VBZ	O	20	SBAR	O
O	O	1698	1706	platelet	platelet	B-NP	NN	B-protein	34	NMOD	B-protein
O	O	1706	1707	-	-	O	HYPH	I-protein	27	P	I-protein
O	O	1707	1717	activating	activate	B-VP	VBG	I-protein	34	NMOD	I-protein
O	O	1718	1724	factor	factor	B-NP	NN	I-protein	34	NMOD	I-protein
O	O	1725	1732	induced	induced	I-NP	JJ	O	34	NMOD	O
O	O	1733	1744	arachidonic	arachidonic	I-NP	JJ	O	34	NMOD	O
O	O	1745	1749	acid	acid	I-NP	NN	O	34	NMOD	O
O	O	1750	1757	release	release	I-NP	NN	O	26	OBJ	O
O	O	1758	1765	perhaps	perhaps	B-ADVP	RB	O	36	VMOD	O
O	O	1766	1772	acting	act	B-VP	VBG	O	26	VMOD	O
O	O	1773	1775	at	at	B-PP	IN	O	36	VMOD	O
O	O	1776	1779	the	the	B-NP	DT	O	39	NMOD	O
O	O	1780	1785	level	level	I-NP	NN	O	37	PMOD	O
O	O	1786	1788	of	of	B-PP	IN	O	39	NMOD	O
T4	B-Protein	1789	1802	phospholipase	phospholipase	B-NP	NN	B-protein	42	NMOD	B-protein
T4	I-Protein	1803	1805	A2	A2	I-NP	NN	I-protein	40	PMOD	I-protein
O	O	1805	1806	.	.	O	.	O	3	P	O

O	O	1807	1809	In	In	B-PP	IN	O	8	VMOD	O
O	O	1810	1817	summary	summary	B-NP	NN	O	1	PMOD	O
O	O	1817	1818	,	,	O	,	O	8	P	O
O	O	1819	1827	platelet	platelet	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	1827	1828	-	-	O	HYPH	I-protein	7	NMOD	I-protein
O	O	1828	1838	activating	activate	B-VP	VBG	I-protein	7	NMOD	I-protein
O	O	1839	1845	factor	factor	B-NP	NN	I-protein	8	SUB	I-protein
O	O	1846	1848	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1849	1854	shown	show	I-VP	VBN	O	8	VC	O
O	O	1855	1859	here	here	I-VP	RB	O	9	VMOD	O
O	O	1860	1862	to	to	I-VP	TO	O	12	VMOD	O
O	O	1863	1867	have	have	I-VP	VB	O	9	VMOD	O
O	O	1868	1869	a	a	B-NP	DT	O	17	NMOD	O
O	O	1870	1876	direct	direct	I-NP	JJ	O	16	AMOD	O
O	O	1877	1880	and	and	I-NP	CC	O	16	AMOD	O
O	O	1881	1889	profound	profound	I-NP	JJ	O	17	NMOD	O
O	O	1890	1896	effect	effect	I-NP	NN	O	12	OBJ	O
O	O	1897	1899	on	on	B-PP	IN	O	12	VMOD	O
O	O	1900	1901	a	a	B-NP	DT	O	23	NMOD	O
O	O	1902	1906	pure	pure	I-NP	JJ	B-cell_line	23	NMOD	B-cell_line
O	O	1907	1908	B	B	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	1909	1913	cell	cell	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	1914	1918	line	line	I-NP	NN	I-cell_line	18	PMOD	I-cell_line
O	O	1918	1919	.	.	O	.	O	8	P	O
